Taro

$75.64
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$1.19 (+1.60%) Today
$0.00 (0.00%) As of 8:00 PM UTC after-hours

Why Robinhood?

You can buy or sell Taro and other stocks, options, and ETFs commission-free!

About TARO

Taro Pharmaceutical Industries Ltd. engages in the development, manufacturing and marketing of prescribed and over-the-counter pharmaceutical products in the U.S., Canada and Israel. Its products include semi-solids formulations, such as creams and ointments and other dosage forms such as liquids, capsules and tablets, in the dermatological and topical, cardiovascular, neuropsychiatric and anti-inflammatory therapeutic categories.

CEO
Uday Vijaykumar Baldota
Employees
1,464
Headquarters
Haifa Bay, Haifa
Founded
1950
Market Cap
2.89B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
32.01K
High Today
$76.00
Low Today
$74.64
Open Price
$75.00
Volume
26.36K
52 Week High
$80.00
52 Week Low
$53.95

TARO Earnings

$0.00
$0.59
$1.17
$1.76
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Estimated
— per share
Actual
Expected May 18, After Hours

You May Also Like

LTRN
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure